The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | Lung cancer molecular testing in the UK

Name: Lung cancer molecular testing in the UK
Uploaded: 2020-01-30T00:00:00Z
Duration: 4 min 38 s
Description: Neal Navani, MA, MRCP, MSc, PhD, Care Quality Improvement Department, Royal College of Physicians, London, UK, discusses how the UK is performing in terms of molecular testing, highlighting real-world evidence from the National Lung Cancer Audit. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Neal Navani • 30 Jan 2020

BTOG 2020

Lung Cancer

Neal Navani, MA, MRCP, MSc, PhD, Care Quality Improvement Department, Royal College of Physicians, London, UK, discusses how the UK is performing in terms of molecular testing, highlighting real-world evidence from the National Lung Cancer Audit. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.